Negative-strand RNA transcripts are produced in human immunodeficiency virus type 1-infected cells and patients by a novel promoter downregulated by Tat

J Virol. 1994 Feb;68(2):979-87. doi: 10.1128/JVI.68.2.979-987.1994.

Abstract

Current understanding of human immunodeficiency virus type 1 (HIV-1) transcription is based on unidirectional expression of transcripts with positive-strand polarity from the 5' long terminal repeat. We now report HIV-1 transcripts with negative-strand polarity obtained from acutely and chronically infected cell lines by use of a template orientation-specific reverse transcriptase-PCR assay. These findings were confirmed in natural infection by analysis of RNA derived from peripheral blood mononuclear cell samples from 15 HIV-1-infected patients. A cDNA derived from a 2.3-kb polyadenylated HIV-1 RNA with negative-strand polarity which encodes a highly conserved 189-amino-acid open reading frame antiparallel to the envelope gene was isolated from acutely infected A3.01 cells. Through use of reporter gene constructions, we further found that a novel negative-strand promoter functions within the negative response element of the 3' long terminal repeat, which is downregulated by coexpression of Tat. Site-directed mutagenesis experiments demonstrated that NF-kappa B I and USF sites are crucial for negative-strand promoter activity. These data extend the coding capacity of HIV-1 and suggest a role for antisense regulation of the viral life cycle.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Amino Acid Sequence
  • Base Sequence
  • Cells, Cultured
  • DNA Mutational Analysis
  • DNA, Complementary / genetics
  • Down-Regulation
  • Gene Expression
  • Gene Expression Regulation, Viral / drug effects*
  • Gene Products, tat / pharmacology*
  • HIV Infections / genetics*
  • HIV-1 / genetics*
  • Humans
  • Molecular Sequence Data
  • NF-kappa B
  • Polymerase Chain Reaction
  • Promoter Regions, Genetic / genetics*
  • RNA, Messenger / biosynthesis
  • RNA, Viral / biosynthesis
  • Sequence Deletion
  • Transcription, Genetic / drug effects*
  • tat Gene Products, Human Immunodeficiency Virus

Substances

  • DNA, Complementary
  • Gene Products, tat
  • NF-kappa B
  • RNA, Messenger
  • RNA, Viral
  • tat Gene Products, Human Immunodeficiency Virus